Skip to main content
Home
language-selector-globe Malaysia | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Malaysia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in Malaysia 
      • Country Leadership Team 
      • Products 
      • Therapeutic Areas 
      • People and Culture 
      • Diversity, Equity and Inclusion 
      • Awards and Recognition 
      Kuala Lumpur About
    • Patients and caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Adverse Event Reporting 
      • Our Process 
      Patient and Doctor Patients and Caregivers
    • Healthcare professionals 
      • Healthcare professional country resource 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Screenshot 2024 07 10 at 7.24 Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      Screenshot 2024 07 10 at 7.14 ESG
    • News 
      • Stories 
      • News Archive 
      Discussion News
    • Careers 
      • Career Search 
      • Meet the Teams 
      • Early Talent 
      • How We Work 
      • Wellbeing 
      Screenshot 2022 03 17 at 09.29 Careers Careers
    • Contact 
    Contacts Contact Us
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division Sort descending
  • Business
  • Functional Area
  • Date Posted
Job Title Site Location Division Sort descending Business Functional Area Date Posted
Senior Accountant, Tax Shanghai (Shanghai) China Finance Corporate Audit & Finance Aug 29, 2024
Order Management Specialist - Temporary INSURGENTES Mexico Finance CTS Audit & Finance Sep 25, 2024
Global FC&C Process Expert (Senior Manager) PIN-PCA Prague Czech Republic Finance CTS Audit & Finance Oct 03, 2024
P2P Service Delivery (SD) Lead NGSC INSURGENTES Mexico Finance CTS Audit & Finance Oct 07, 2024
Finance Control and Compliance US Manager INSURGENTES Mexico Finance CTS Audit & Finance Oct 08, 2024
General Accounting Manager INSURGENTES Mexico Finance CTS Audit & Finance Oct 09, 2024
Procure to Pay Business Partner Management INSURGENTES Mexico Finance CTS Audit & Finance Oct 16, 2024
Alternant CONTRÔLE DE GESTION - BPA Paris Headquarter (Novartis Pharma S.A.S.) France Finance Innovative Medicines Others May 17, 2024
Procure to Pay Senior Specialist MR11 INSURGENTES Mexico Finance CTS Audit & Finance Jul 23, 2024
Order to Cash Radioligand Therapy Sr. Specialist INSURGENTES Mexico Finance CTS Audit & Finance Aug 06, 2024
Record to Report Specialist INSURGENTES Mexico Finance CTS Audit & Finance Sep 05, 2024
Revenue Accounting Manager Shanghai (Shanghai) China Finance CTS Audit & Finance Jul 17, 2024
Medical Content Lead (m/w/d), Hematology Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Research & Development Sep 09, 2024
县域主任/县域主管 Yibin (Sichuan Province) China International Innovative Medicines Sales Sep 10, 2024
MR Pingxiang (Jiangxi Province) China International Innovative Medicines Sales Sep 23, 2024
District Manager Haerbin (Heilongjiang Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)地区经理 Bozhou (Anhui Province) China International Innovative Medicines Sales Sep 24, 2024
(高级)医药代表 /(资深)产品专员 Taiyuan (Shanxi Province) China International Innovative Medicines Sales Sep 24, 2024
县域主任(主管) Luoyang (Henan Province) China International Innovative Medicines Sales Sep 26, 2024
(高级)医药代表 /(资深)产品专员 Xian (Shanxi Province) China International Innovative Medicines Sales Sep 29, 2024
Therapy Area Partner Abha Saudi Arabia International Innovative Medicines Sales Oct 01, 2024
(高级)医药代表 /(资深)产品专员 Kunming (Yunnan Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Chongqing (Chongqing Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Guiyang (Guizhou Province) China International Innovative Medicines Sales Oct 11, 2024
Senior MR Shenzhen (Guangdong Province) China International Innovative Medicines Sales Oct 14, 2024
Project Team Coordinator (Medical) (m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Research & Development Oct 15, 2024
Sales Representative (w/m/d), TA: Immunologie, Gebiet: Brandenburg Brandenburg (Novartis Pharma GmbH) Germany International Innovative Medicines Sales Oct 16, 2024
Netzwerk Manager (m/w/d), Prostate Cancer, Saarland und Rheinland-Pfalz Saarland (Novartis Pharma GmbH) Germany International Innovative Medicines Sales Oct 16, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
Sales Representative Neuroscience (m/w/d) Hessen Hessen (Novartis Pharma GmbH) Germany International Innovative Medicines Sales Oct 17, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Sales Oct 17, 2024
Trainee Marketing (m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germany International Innovative Medicines Marketing Oct 18, 2024
Sales Representative Onkologie (d/w/m), Gebiet: Bremen Bremen (Novartis Pharma GmbH) Germany International Innovative Medicines Sales Oct 18, 2024
Medical Scientific Liaison Manager, Immunologie (w/m/d), Gebiet: Sachsen Saxony (with Corpus Christi) (Novartis Pharma GmbH) Germany International Innovative Medicines Research & Development Oct 18, 2024
Lead, Integrated Insights & Planning_市場調査 Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Marketing Oct 07, 2024
Associate, TA Medical (General Medicines) Head Office (Japan) (Pharmaceuticals) Japan International Innovative Medicines Research & Development Oct 07, 2024
(高级)医药代表 /(资深)产品专员 Kunming (Yunnan Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Chongqing (Chongqing Province) China International Innovative Medicines Sales Oct 09, 2024
(高级)医药代表 /(资深)产品专员 Nanjing (Jiangsu Province) China International Innovative Medicines Sales Oct 10, 2024
(高级)医药代表 /(资深)产品专员 Guiyang (Guizhou Province) China International Innovative Medicines Sales Oct 11, 2024
Senior MR Shenzhen (Guangdong Province) China International Innovative Medicines Sales Oct 14, 2024
(高级)医药代表 /(资深)产品专员 Kuerle (Xinjiang Province) China International Innovative Medicines Sales Oct 16, 2024
MR Changsha (Hunan Province) China International Innovative Medicines Sales Oct 17, 2024
MR Enshi (Hubei Province) China International Innovative Medicines Sales Oct 22, 2024
(高级)医药代表 /(资深)产品专员 Anqing (Anhui Province) China International Innovative Medicines Sales Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 23, 2024
(高级)医药代表 /(资深)产品专员 Ningbo (Zhejiang Province) China International Innovative Medicines Sales Oct 24, 2024
(高级)医药代表 /(资深)产品专员 Chuxiong (Yunnan Province) China International Innovative Medicines Sales Oct 25, 2024
(高级)医药代表 /(资深)产品专员 Shanghai (Shanghai) China International Innovative Medicines Sales Oct 25, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 42
  • › Next page

Novartis Malaysia

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • Press Releases and Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2024 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in Malaysia